Damrot, J; Nubel, T; Epe, B et al.
Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide.Br J Pharmacol. Bd. 149. H. 8. 2006 S. 988-97
Hermisson, M; Klumpp, A; Wick, W et al.
O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells.J Neurochem. Bd. 96. H. 3. 2006 S. 766-76
Kaina, B; Christmann, M
O6-Methylguanine-dNA methyltransferases (alkyltransferases)Ganten (Hrsg). Encyclopedic Reference of Genomic and Proteomics in Molecular Medicine. Springer-Verlag 2006
Hengstler, J. G.; Bockamp, E. O.; Hermes, M. et al.
Oneogene-blocking therapies: New insights from conditional mouse tumor modelsCURRENT CANCER DRUG TARGETS. Bd. 6. H. 7. 2006 S. 603-612
McGurk, CJ; Cummings, M; Koberle, B et al.
Regulation of DNA repair gene expression in human cancer cell lines.J Cell Biochem. Bd. 97. H. 5. 2006 S. 1121-36
Fritz, G; Kaina, B
Rho GTPases: promising cellular targets for novel anticancer drugs.Curr Cancer Drug Targets. Bd. 6. H. 1. 2006 S. 1-14
Vodicka, P; Koskinen, M; Naccarati, A et al.
Styrene metabolism, genotoxicity and potential carcinogenicityDrug Metab Rev. Bd. 38. 2006 S. 805-53
Muhlhausen, U; Schirrmacher, R; Piel, M et al.
Synthesis of 131I-labeled glucose-conjugated inhibitors of O6-methylguanine-DNA methyltransferase (MGMT) and comparison with nonconjugated inhibitors as potential tools for in vivo MGMT imaging.J Med Chem. Bd. 49. H. 1. 2006 S. 263-72
Bockamp, Ernesto; Antunes, Cecilia; Maringer, Marko et al.
Tetracycline-controlled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kit-expressing lineage-negative hematopoietic cellsBLOOD. Bd. 108. H. 5. 2006 S. 1533-1541
Schmidt, S; Debensason, D; Mühlan, H et al.
The DISABKIDS generic quality of life instrument showed cross-cultural validity.J Clin Epidemiol. Bd. 59. H. 6. 2006 S. 587-98